Actos Attorneys in St. Louis, MO and Metro-East Illinois

Actos dangerous medication.Our Actos bladder cancer lawyers are investigating cases where diabetes patients developed bladder cancer after taking Actos.  Actos (pioglitazone) is a drug designed to treat type II diabetes and has been linked to a high incidence of bladder cancer.

If you or someone you love has been the victim of Actos bladder cancer in the St. Louis, MO area, you may be entitled to collect significant compensation in an Actos bladder cancer dangerous drug lawsuit.  Our experienced St. Louis Actos bladder cancer lawyer team can help you determine the best course of action in a free legal consultation.

Contact our pharmaceutical product liability law firm to discuss your case with Actos bladder cancer lawyers at our St. Louis or Metro-East Illinois office.  We offer:

  • Free claim evaluations by a local Actos bladder cancer lawyer
  • Home and hospital visits anywhere in Missouri or Illinois
  • No fee unless we win your case


Actos Bladder Cancer

Actos (pioglitazone) is a type II diabetes drug manufactured by Takeda Pharmaceuticals that has been linked to a higher incidence of bladder cancer. In 2010, more than 2 million diabetes patients were prescribed Actos.

In 2010, the first FDA Actos bladder cancer warning was issued when preliminary data from an ongoing 10-year study run by Takeda Pharmaceuticals pointed to a heightened risk of Actos bladder cancer that grows the longer the drug is taken.  The study is still in progress and the FDA has not yet released any conclusions to the investigation

Italian researchers released a study in May 2011 that cited a disproportionately high incidence of bladder cancer in Actos patients after researching FDA Actos adverse event system records.    The FDA issued a second Actos bladder cancer communication in June 2011, warning that the risk of developing Actos bladder cancer is increased the longer a person takes the drug.


Actos Bladder Cancer Recalls

French and German officials suspended Actos sales after gathering increasing evidence linking Actos to bladder cancer.  France later issued a formal Actos recall, and has also recalled Campetact, a related drug known as ActosplusMet in the United States, has also been recalled in France.  Regulators from other European Countries, Canada, and the United States are currently holding meetings to discuss the link between Actos and bladder cancer in preparation for a possible Actos recall.


Actos Bladder Cancer Lawsuits

In 2010, Actos sales topped $3.4 billion, and Actos is Takeda Pharmaceuticals’ best-selling drug.   A number of Actos patients in the St. Louis and Metro-East Illinois area have filed Actos bladder cancer lawsuits in pursuit of compensation for damages such as medical bills, pain and suffering, and lost wages due to illness.  In these Actos lawsuits, plaintiffs claim that Takeda Pharmaceuticals knew or should have known of the risk of Actos bladder cancer but failed to warn patients and the medical community of the risk of Actos bladder cancer.  If you believe you may have an Actos bladder cancer lawsuit in the St. Louis area, it is in your best interests to contact a St. Louis Actos lawyer before a statute of limitations prevents you from filing an Actos bladder cancer lawsuit claim.


Experienced St. Louis Actos Bladder Cancer Lawyers

Our St. Louis and Metro-East Illinois Actos Bladder Cancer lawyers are currently accepting cases.  If you or someone you love developed bladder cancer after taking Actos, you may be entitled to collect substantial compensation for your damages in a product liability lawsuit.  Contact our Greater St. Louis Actos bladder cancer law firm today for a free legal consultation.